Published in
Taylor and Francis Group, Expert Opinion on Biological Therapy, 9(17), p. 1053-1063, 2017
DOI: 10.1080/14712598.2017.1346607
Links
Tools
Endoglin-based biological therapy in the treatment of angiogenesis-dependent pathologies
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 